Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company ...

AirNet remains fully committed to addressing the bid price deficiency during this extended compliance period. If the Company’s closing bid price meets or exceeds $1 per ADS for a minimum of 10 ...

China SXT Pharmaceuticals, Inc. (Nasdaq: SXTC) (the “Company”), a specialty pharmaceutical company focusing on the research, ...

In January 2025, the Securities and Exchange Commission (the Commission) approved amendments to the minimum bid price ...

Aptose Biosciences announced it regained compliance with Nasdaq’s minimum bid price requirement, as its shares maintained a closing bid price of $1.00 or grea ...

SaverOne 2014 (SVRE) announced that it received formal written confirmation from The Nasdaq Stock Market confirming that the Company has ...

The Company has been granted a 180-day period to regain compliance with Nasdaq's minimum bid price requirement, providing a structured timeline for corrective measures. Powell Max Limited's shares ...

"Maintaining compliance reflects our commitment to strong corporate governance and reinforces our dedication to creating long ...

HWH International Inc. (NASDAQ:HWH) has received a notification from The Nasdaq Stock Market LLC confirming that the company is back in compliance with the Nasdaq’s minimum bid price requirement.

Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib ...

Playstudios, Inc (MYPS) has disclosed a new risk, in the Share Price & Shareholder Rights category. Playstudios, Inc. faces a significant business ...